Donepezil should be tapered gradually, not stopped all at once. The standard approach is to reduce the dose to the next lowest level every two to four weeks until you reach the starting dose, then discontinue after a final period at that lowest dose. Abrupt withdrawal can trigger serious symptoms including hallucinations, agitation, delirium, and a sharp worsening of dementia that may not be fully reversible.
Why Gradual Tapering Matters
Donepezil works by boosting a brain chemical involved in memory and attention. When the drug is removed suddenly, the brain can overreact to the abrupt change. This is sometimes called cholinergic rebound, and it can produce symptoms that look alarming: intense hallucinations, severe agitation, insomnia, fluctuating consciousness, and anxiety. In one documented case, a patient developed delirium within three days of abrupt discontinuation, with two nights of complete sleeplessness and visible hallucinations.
There’s also a cognitive cost. Research shows that the cognitive benefits of donepezil only persist if treatment is restarted within about three weeks of stopping. If the gap extends beyond six weeks, those benefits are unlikely to be fully recovered even after restarting the medication, because the underlying disease continues to progress in the background. A slow taper gives you time to catch problems early and reverse course if needed.
The Standard Taper Schedule
The general principle is to cut the dose by roughly 50% every four weeks until reaching the lowest available dose, then stop after four weeks at that level. In practice, this looks different depending on the starting dose.
From 10 mg: Reduce to 5 mg daily for one month, then discontinue. This is the most common scenario and the most straightforward taper.
From 23 mg: Step down to 10 mg daily for two to four weeks, then to 5 mg daily for another two to four weeks, then stop. The higher the starting dose, the more important a gradual stepdown becomes.
Some clinical protocols move in two-week intervals rather than four. The key is making only one change at a time and waiting long enough to observe the effects before making the next reduction. Faster tapers (over two weeks per step) are sometimes used when side effects demand quicker action, but a slower pace makes it easier to spot problems.
What to Watch For During the Taper
Most behavioral worsening occurs within the first six weeks of withdrawal. The symptoms to track include increased agitation or aggression, new or worsening hallucinations or delusions, noticeable weight loss, reduced alertness or consciousness, and a decline in the ability to perform daily tasks. These changes can appear at any step of the taper, not just after the final dose is stopped.
Donepezil has an unusually long half-life of about 80 hours, meaning it takes roughly two to three weeks for the drug to fully clear the body after a dose change. This is why symptoms don’t always appear immediately. A change made on Monday might not show its full effect until the following week. It also means the body adjusts slowly, which is one reason the recommended waiting period between dose reductions is at least two weeks.
Caregivers are essential during this process. The person taking donepezil often cannot reliably report their own cognitive changes. Family members and caregivers are in the best position to notice shifts in behavior, sleep patterns, mood, and daily functioning. Keeping a simple daily log of alertness, mood, appetite, and any unusual behaviors can help the prescriber decide whether to continue the taper or pause.
When to Restart the Medication
If distressing symptoms emerge during the taper, the medication can be restarted at the lowest effective dose. The decision to restart should happen promptly. Because cognitive benefits become harder to recover the longer the drug is withheld, the three-week window is an important benchmark. If worsening appears related to stopping the medication rather than natural disease progression, restarting sooner gives the best chance of regaining lost ground.
Distinguishing between withdrawal effects and disease progression can be tricky. Timing is the most useful clue. Symptoms that appear within days to weeks of a dose change are more likely withdrawal-related. A gradual decline that was already underway before the taper began is more likely the disease itself. This is another reason slow tapers are preferred: they make the cause of any changes easier to identify.
Reasons Donepezil Gets Stopped
Periodic reassessment of donepezil is recommended every three to six months. The medication is typically considered for discontinuation when the person no longer appears to be benefiting from treatment, when side effects (particularly gastrointestinal or cardiovascular) outweigh the cognitive benefits, or when dementia has progressed to a stage where maintaining cognition is no longer the primary goal of care.
In advanced or end-stage dementia, when a person is dependent in most basic activities of daily living or can no longer meaningfully respond to their environment, continuing donepezil may not align with comfort-focused care goals. Canadian consensus guidelines specifically recommend considering discontinuation in these circumstances, with the same gradual taper approach. Even in palliative settings, abrupt cessation is discouraged unless there’s an immediate safety concern from continuing the drug.
Practical Tips for the Taper Period
Keep the prescriber informed throughout the process. Before starting the taper, establish a plan for how often you’ll check in, whether by phone, video, or in-person visit. Many clinicians schedule a touchpoint at each dose reduction step.
Maintain as much routine and stability as possible in the person’s daily life during the taper. Introducing other major changes (new living environment, new caregivers, altered daily schedule) at the same time makes it nearly impossible to tell what’s causing any behavioral shifts. If a move to a new care setting is planned, it’s generally better to complete one transition before starting the other.
Don’t adjust other medications at the same time unless medically necessary. Changing multiple drugs simultaneously obscures the source of any new symptoms. If the person is also taking memantine, the two medications are typically tapered separately rather than simultaneously.